Review of the implementation of plasma ctDNA testing on behalf of IQN Path ASBL: a perspective from an EQA providers’ survey-Reference-Cited by-同舟云学术

Review of the implementation of plasma ctDNA testing on behalf of IQN Path ASBL: a perspective from an EQA providers’ survey

Published:2017-08-25 Issue:6 Volume:471 Page:809-813
ISSN:0945-6317
Container-title:Virchows Archiv
language:en
Short-container-title:Virchows Arch

Author:

Deans Zandra C., ,Williams Hannah,Dequeker Elisabeth M. C.,Keppens Cleo,Normanno Nicola,Schuuring Ed,Patton Simon J.,Cheetham Melanie,Butler Rachel,Hall Jacqueline A.

Publisher

Springer Science and Business Media LLC

Subject

Cell Biology,Molecular Biology,General Medicine,Pathology and Forensic Medicine

Link

http://link.springer.com/article/10.1007/s00428-017-2222-z/fulltext.html

Reference12 articles.

1. Cree IA, Deans Z, Ligtenberg MJ, Normanno N, Edsjo A, Rouleau E, Sole F, Thunnissen E, Timens W, Schuuring E, Dequeker E, Murray S, Dietel M, Groenen P, Van Krieken JH, European Society of Pathology Task Force on Quality Assurance in Molecular Pathology, Royal College of Pathologists (2014) Guidance for laboratories performing molecular pathology for cancer patients. J Clin Pathol 67:923–931. https://doi.org/10.1136/jclinpath-2014-202404

2. Dubbink HJ, Deans ZC, Tops BB, van Kemenade FJ, Koljenovic S, van Krieken HJ, Blokx WA, Dinjens WN, Groenen PJ (2014) Next generation diagnostic molecular pathology: critical appraisal of quality assurance in Europe. Mol Oncol 8:830–839. https://doi.org/10.1016/j.molonc.2014.03.00410.1016/j.molonc.2014.03.004

3. Rolfo C, Castiglia M, Hong D, Alessandro R, Mertens I, Baggerman G, Zwaenepoel K, Gil-Bazo I, Passiglia F, Carreca AP, Taverna S, Vento R, Peeters M, Russo A, Pauwels P (2014) Liquid biopsies in lung cancer: the new ambrosia of researchers. Biochim Piophys Acta 1846:539–546. https://doi.org/10.1016/j.bbcan.2014.10.001

4. Douillard JY, Ostoros G, Cobo M, Ciuleanu T, Cole R, McWalter G, Walker J, Dearden S, Webster A, Milenkova T, McCormack R (2014) Gefitinib treatment in EGFR mutated caucasian NSCLC: circulating-free tumour DNA as a surrogate for determination of EGFR status. J Thorac Oncol 9:1345–1353. https://doi.org/10.1097/JTO.0000000000000263

5. Normanno N, Rachiglio AM, Roma C, Fenizia F, Esposito C, Pasquale R, La Porta ML, Iannaccone A, Micheli F, Santangelo M, Bergantino F, Costantini S, De Luca A (2013) Molecular diagnostics and personalised medicine in oncology: challenges and opportunities. J Cell Biochem 114:514–524. https://doi.org/10.1002/jcb.24401

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The changing face of circulating tumor DNA (ctDNA) profiling: Factors that shape the landscape of methodologies, technologies, and commercialization;Medizinische Genetik;2023-11-29

2. A pocket companion to cell-free DNA (cfDNA) preanalytics;Tumor Biology;2023-10-12

3. Pre-analytical conditions and implementation of quality control steps in liquid biopsy analysis;Critical Reviews in Clinical Laboratory Sciences;2023-07-30

4. Implementation of circulating tumour DNA multi-target mutation testing in plasma: a perspective from an external quality assessment providers’ survey;Virchows Archiv;2023-05-19

5. Liquid biopsies, are we ready for prime time?;Journal for ImmunoTherapy of Cancer;2023-02